Company / Operating Income per Share
Oruka Therapeutics, Inc. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$5.25
FY2024
5-year range
-$5.25 / -$0.51
FY2020-FY2024
Trend
-936.7%
vs FY2023
Sector context
#171 of 201
Health Care
What the data says
Operating Income per Share changed -937% YoY in FY2024, a notable deviation from the 9-year average annual change of -144%.
Based on SEC 10-K filings.
-5.25 in FY2024.
Declined from $-1.34 to $-5.25 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 201This company -$5.25 Sector average -$3.23
▼
-62.3% below sector average
Key checks
Key Insights
- In FY2024, operating income per share decreased 936.7% year-over-year.
- Ranks #171 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$5.25 | -936.7% |
| FY2023 | -$0.51 | +62.3% |
| FY2022 | -$1.34 | -31.2% |
| FY2021 | -$1.02 | +72.0% |
| FY2020 | -$3.65 | +65.2% |
| FY2019 | -$10.49 | -560.4% |
| FY2018 | -$1.59 | +13.1% |
| FY2017 | -$1.83 | -44.5% |
| FY2016 | -$1.27 | +60.5% |
| FY2015 | -$3.21 | -625.1% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026